Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.
第一作者:
Alberto,Peláez-García
第一单位:
Department of Pathology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.;Molecular Pathology and Therapeutic Targets Group, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.;Molecular Pathology Diagnostic Unit, Hospital Universitario La Paz, INGEMM, IdiPAZ, Madrid, Spain.
作者:
医学主题词
脂肪因子类(Adipokines);乳腺肿瘤(Breast Neoplasms);钙结合蛋白质类(Calcium-Binding Proteins);钙调蛋白(Calmodulin);载体蛋白质类(Carrier Proteins);细胞因子受体gp130(Cytokine Receptor gp130);细胞外基质蛋白质类(Extracellular Matrix Proteins);女(雌)性(Female);糖蛋白类(Glycoproteins);人类(Humans);免疫组织化学(Immunohistochemistry);凋亡抑制蛋白质类(Inhibitor of Apoptosis Proteins);胞间信号肽类和蛋白质类(Intercellular Signaling Peptides and Proteins);Ki-67抗原(Ki-67 Antigen);中年人(Middle Aged);氧化还原酶类(作用于CH-CH键供体)(Oxidoreductases Acting on CH-CH Group Donors);蛋白质类(Proteins);受体, 雌激素(Receptors, Estrogen);受体, 孕酮(Receptors, Progesterone);核糖体蛋白质类(Ribosomal Proteins);泛素缀合酶类(Ubiquitin-Conjugating Enzymes)
DOI
10.1371/journal.pone.0183452
PMID
28886093
发布时间
2023-12-13
- 浏览40
PloS one
e0183452页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



